Michael B Sheffery - Net Worth and Insider Trading
Michael B Sheffery Net Worth
The estimated net worth of Michael B Sheffery is at least $176 Million dollars as of 2024-09-20. Michael B Sheffery is the Director of Supernus Pharmaceuticals Inc and owns about 5,475,286 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $176 Million. Details can be seen in Michael B Sheffery's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael B Sheffery has not made any transactions after 2012-05-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael B Sheffery
Michael B Sheffery Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael B Sheffery owns 2 companies in total, including Supernus Pharmaceuticals Inc (SUPN) , and Athersys Inc (ATHXQ) .
Click here to see the complete history of Michael B Sheffery’s form 4 insider trades.
Insider Ownership Summary of Michael B Sheffery
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SUPN | Supernus Pharmaceuticals Inc | 2012-05-04 | director |
ATHXQ | Athersys Inc | 2008-05-13 | director |
Michael B Sheffery Latest Holdings Summary
Michael B Sheffery currently owns a total of 1 stock. Michael B Sheffery owns 5,475,286 shares of Supernus Pharmaceuticals Inc (SUPN) as of May 4, 2012, with a value of $176 Million.
Latest Holdings of Michael B Sheffery
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SUPN | Supernus Pharmaceuticals Inc | 2012-05-04 | 5,475,286 | 32.10 | 175,756,681 |
Holding Weightings of Michael B Sheffery
Michael B Sheffery Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael B Sheffery has made a total of 0 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years. The most-recent trade in Supernus Pharmaceuticals Inc is the acquisition of 1,100,000 shares on May 4, 2012, which cost Michael B Sheffery around $6 Million.
Insider Trading History of Michael B Sheffery
- 1
Michael B Sheffery Trading Performance
GuruFocus tracks the stock performance after each of Michael B Sheffery's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael B Sheffery is 97.82%. GuruFocus also compares Michael B Sheffery's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael B Sheffery within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael B Sheffery's insider trading performs compared to the benchmark.
Performance of Michael B Sheffery
Michael B Sheffery Ownership Network
Michael B Sheffery Owned Company Details
What does Supernus Pharmaceuticals Inc do?
Who are the key executives at Supernus Pharmaceuticals Inc?
Michael B Sheffery is the director of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .
Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary
Over the past 18 months, Michael B Sheffery made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 98,505 shares made by Padmanabh P. Bhatt , a net sale of 21,235 shares made by Tami Tillotson Martin , and a net sale of 13,886 shares made by Georges Gemayel .
In summary, during the past 3 months, insiders sold 13,886 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 13,886 shares. During the past 18 months, 146,329 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 146,329 shares.
Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Supernus Pharmaceuticals Inc Insider Transactions
Michael B Sheffery Mailing Address
Above is the net worth, insider trading, and ownership report for Michael B Sheffery. You might contact Michael B Sheffery via mailing address: 601 Lexington Avenue, 54th Floor, New York Ny 10022.